State licence monitor
New York Compounding Pharmacy License and Regulation Monitor
How compounding pharmacy licensure, sterile compounding permissions and disciplinary records work in New York, and which official sources hold them.
New York hosts 2 of the 96 FDA-registered outsourcing facilities, ranking 14 of 28 states by facility count. New York regulates pharmacy through the State Education Department rather than a standalone board of pharmacy. Compounding pharmacies operating in New York are licensed by the state, while 503B outsourcing facilities additionally register with FDA — two separate systems that are frequently confused. This page describes where New York records live and how to check them. No entity-specific licence status is asserted here.
Key findings
- 2 of the 96 federally registered outsourcing facilities are located in New York — 14 of 28 states by count.
- New York regulates pharmacy through the State Education Department rather than a standalone board of pharmacy.
- State licensure and FDA 503B registration are separate systems with separate registers.
- A pharmacy shipping into New York from another state generally requires a nonresident licence.
- Licence status, expiration and disciplinary history change continuously and must be checked live.
- No individual pharmacy's New York licence status is asserted on this page.
| Regulator | Verification Pending New York board of pharmacy — register link pending verification |
|---|---|
| Resident pharmacy licence | Verification Pending |
| Nonresident licence requirement | Verification Pending |
| Sterile compounding permission | Verification Pending |
| 503B state permitting | Verification Pending |
| Disciplinary record source | Verification Pending |
| 503B facilities located here | 2 of 96 — Galaxy Pharmaceuticals, LLC, Pine Pharmaceuticals, LLC |
| Current state alerts | No Public Evidence Found |
Where does New York sit in the national picture?
New York hosts 2 of the 96 registered outsourcing facilities, ranking 14 of 28 states with any. Across the Northeast, 21 registrations are held in total, the largest being NJ (10), PA (5), CT (2). Facility count is a measure of where sterile compounding capacity is registered, not a measure of quality, safety, or oversight intensity in this state.
For a patient, the practical consequence is that the pharmacy dispensing their preparation may be licensed in New York, or may be an out-of-state facility holding a New York nonresident licence. Both are checkable, but they sit in different registers.
How is compounding regulated in New York?
Two systems apply simultaneously and they answer different questions. New York's board of pharmacy licenses the pharmacy itself — the premises, the pharmacist-in-charge, and in many states a separate permission for sterile compounding. That licence is what makes it lawful for the pharmacy to operate and to dispense within the state.
The federal layer is different. Section 503A describes conditions under which drug products compounded by a licensed pharmacist in a state-licensed pharmacy, or by a licensed physician, are exempt from FDA approval, CGMP, and adequate-directions-for-use requirements. FDA A pharmacy operating under section 503A remains a state-licensed pharmacy; it does not register with FDA as a facility.
If instead a compounder registers with FDA as a 503B outsourcing facility, a further set of obligations attaches. Drugs compounded by an outsourcing facility can qualify for exemptions from FDA approval requirements and from the requirement to label products with adequate directions for use, but not from current good manufacturing practice requirements. FDA Notably, New York licensure and FDA registration are not substitutes: an outsourcing facility that loses a state licence does not thereby lose its federal registration, and vice versa.
What does a New York licence actually tell you?
It tells you that the entity satisfied the board's requirements at the time of issue and that the licence had not lapsed or been acted against as of the date you checked. That is genuinely useful and it is checkable in minutes.
It does not tell you that any particular preparation was made correctly, that the facility passed its most recent inspection, or that no enforcement action is pending. Licence status and product quality are different questions answered by different records.
Which records exist, and who holds them
| Record | Held by | What it establishes | What it does not establish |
|---|---|---|---|
| Resident pharmacy licence | New York board of pharmacy | The pharmacy is licensed to operate in-state | Product quality or inspection outcome |
| Nonresident licence | New York board of pharmacy | An out-of-state pharmacy may ship in | Anything about the home-state record |
| Sterile compounding permission | New York board of pharmacy | Scope of permitted compounding | Compliance at any given moment |
| 503B registration | FDA | The facility registered as an outsourcing facility | FDA approval or CGMP compliance |
| Form 483 observations | FDA | Investigator observations at an inspection | A final agency finding |
| Warning letter | FDA | A stated agency position on specific violations | Current standing without closeout status |
| Recall | FDA enforcement reports | Specific products and lots were recalled | That other products were affected |
| Disciplinary order | New York board of pharmacy | A board action was taken | Finality, where appeal rights remain |
What this means
- New York maintains a public licence register that can be checked directly.
- State licensure and federal registration are separate and must both be checked.
- Nonresident licensing means the relevant board may not be the one you expect.
What this does not mean
- That this page reports any specific pharmacy's licence status.
- That a licence implies product quality or inspection outcome.
- That the absence of a disciplinary record proves none exists.
- The New York board register has not been captured at this snapshot, so no live licence data is published here.
- State requirements change through rulemaking and legislation; this description is general.
- Nonresident requirements differ by the shipping state as well as the receiving state.
- Disciplinary records vary in how long they remain published and whether appeals are shown.
What does the New York board of pharmacy actually do?
Every US state operates a pharmacy regulator, and its powers are broadly similar even where the agency's name differs. In New York the board is the authority that can confirm whether a pharmacy is lawfully operating today — a question no federal register can answer for a 503A compounder.
The functions below are the ones that matter for verifying a compounding pharmacy. Note that only the first is a simple yes/no; the rest require reading a record rather than checking a box.
| Board function | What it establishes |
|---|---|
| Issues and renews the pharmacy permit or licence that makes it lawful to operate premises in the state. | — |
| Licenses individual pharmacists and, in most states, pharmacy technicians. | — |
| Sets or adopts compounding standards, most commonly by adopting USP chapters by reference. | — |
| Inspects licensed premises, on a schedule and on complaint. | — |
| Investigates complaints and issues disciplinary orders — the record that shows whether action has been taken. | — |
| Licenses or registers nonresident pharmacies that ship into the state from elsewhere. | — |
Why nonresident licensure matters for New York patients
A patient receiving medication by post from another state is being served by a pharmacy their own board did not license. Nonresident licensure closes that gap by asserting authority over any pharmacy dispensing into the state.
The practical consequence is that two boards are usually involved in a mail-order prescription, and they hold different records. The home-state board holds the primary licence and most disciplinary history; the receiving state's board holds the nonresident registration and can act on it independently.
Verifying one does not verify the other. A pharmacy in good standing at home can have a lapsed or disciplined nonresident licence elsewhere, and the reverse is also possible.
What to check, and which record answers it
| What to check | Record that holds it | What a result does and does not establish |
|---|---|---|
| Licence exists and is current | State board public register | Confirms lawful operation on the date checked — nothing about product quality |
| Licence class covers sterile compounding | Board register or permit detail | Many states license sterile compounding separately from general pharmacy |
| Nonresident licence, if shipping in | Receiving state's board | The home-state licence does not cover interstate dispensing |
| Disciplinary history | Board orders and minutes | Orders vary in finality; several remain appealable |
| Federal 503B registration, if claimed | FDA outsourcing facility list | A 503B claim absent from the federal list is a serious discrepancy |
| Pharmacist-in-charge | Board register | Names the individual accountable for the premises |
Registered outsourcing facilities located in New York
| Registered facility name | Location |
|---|---|
| Galaxy Pharmaceuticals, LLC | Albany, NY |
| Pine Pharmaceuticals, LLC | Tonawanda, NY |
These 2 appear on FDA's register as of 2026-07-23. Registration is a federal filing and is not FDA approval. Registration means only that FDA has received the information required to register the facility. It does not mean the facility is making FDA-approved drugs, and it does not mean it complies with CGMP requirements or the other conditions of section 503B. FDA
Each is a separate facility record. Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA
- The New York board register has not been captured at this snapshot, so no live licence data appears here.
- Board requirements change through rulemaking; this describes the general structure, not current rule text.
- Facility counts describe federal registrations only and say nothing about 503A pharmacy numbers.
- Disciplinary records vary in retention period and in whether appeals are shown alongside orders.
Provider availability in New York
Most patients receiving compounded preparations are served by a telehealth provider rather than by walking into a pharmacy, so provider coverage is part of the practical picture in any state. NexLife states that it operates in all 50 states and the District of Columbia, subject to licensure, with flat-rate pricing from $145 per month verified by recomputation on this platform.
'Subject to licensure' is the operative phrase and it is not boilerplate. A telehealth provider needs a prescriber licensed in the patient's state, and the dispensing pharmacy needs either a resident licence there or a nonresident licence to ship in. Both must hold for the state you are actually in, and either can lapse independently.
| What must hold in New York | Record that confirms it | Status |
|---|---|---|
| Prescriber licensed in your state | Named clinician plus a state licence lookup | Verification Pending |
| Dispensing pharmacy licensed to ship to you | Resident or nonresident licence on your state board's register | Verification Pending |
| Programme actually available at your address | Confirmed at intake before payment | Verification Pending |
Full verified pricing across all three protocols: affordability pages.
Federal sources verified for this page — 4 sources
- FDA — Information for Outsourcing Facilitieschecked 2026-07-23
- FDA — Q&A: Outsourcing Facility Registrationchecked 2026-07-23
- FDA — Registered Outsourcing Facilitieschecked 2026-07-23
- FDA — Aligning Federal and State Regulation of Compounderschecked 2026-07-23
Related records in this section
Section hub: State licence monitors · Methodology · Status definitions · Right to respond
Frequently asked questions
How do I check whether a pharmacy is licensed in New York?
Search the New York board of pharmacy's public licence register directly. A licence verified today can lapse tomorrow, so check it at the point you need it.
Does a pharmacy need a New York licence to ship here from another state?
Generally yes — most states require a nonresident licence or registration. Confirm the current requirement with the New York board.
Is a 503B outsourcing facility also state licensed?
Frequently, and the two are separate. Federal registration does not replace a state licence, and losing one does not automatically affect the other.
Does FDA registration mean the facility is approved?
No. Registration means only that FDA has received the information required to register the facility. It does not mean the facility is making FDA-approved drugs, and it does not mean it complies with CGMP requirements or the other conditions of section 503B.
Does this page list pharmacies licensed in New York?
Not at this snapshot. No entity-specific licence status has been verified, so none is published.
Sources
- FDA — Information for Outsourcing Facilities
- FDA — Q&A: Outsourcing Facility Registration
- FDA — Registered Outsourcing Facilities
- FDA — Aligning Federal and State Regulation of Compounders
Update history
| Date | Change |
|---|---|
| 2026-07-23 | Record published at current snapshot. |
Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.